From primary active botanical screening to bioassay-backed clinical research, browse our integrated core contract offerings.
Understanding shifting consumer behavior, supply chain modernization, and the migration from empirical herbs to quantified bioactive complexes.
The global dietary supplement market has moved past simple powder blending. Leading multi-national nutraceutical distributors now demand mechanistic biomarker validation, standardized HPLC fingerprints, and human clinical trials to substantiate therapeutic claims across North America and the European Union.
China commands over 65% of global botanical raw extraction volume. Leveraging native cultivation clusters across Sichuan, Yunnan, Hunan, and Guizhou, domestic manufacturers provide unmatched economies of scale while integrating real-time traceability and strict heavy-metal compliance.
With US FDA 21 CFR Part 111, EU EFSA Novel Food protocols, and health authority audits on botanical adulteration, supplier verification requires robust HPTLC identification, genomic barcoding, and zero-residual ethylene oxide processing standards.
A closed-loop pathway translating raw herbal matrices into scalable, compliant finished consumer delivery formats.
High-throughput profiling of plant secondary metabolites including polyphenols, ginsenosides, and alkaloids using advanced LC-MS/MS platforms.
Quantifying active yield fluctuations across diverse regional topographies and distinct growth seasons to guarantee standardizable raw inputs.
Validation of reference standards via HPLC, GC, and HPTLC chromatographic fingerprints matching USP, EP, and ChP regulatory frameworks.
Pilot-scale process parameters: supercritical CO2 fluid extraction, macroporous resin adsorption, ultrafiltration, and vacuum spray-drying.
Establishing cell metabolic pathways, antioxidant cytotoxicity panels, LD50 profiles, and comprehensive Ames mutagenicity tests.
Conducting randomized, double-blind, placebo-controlled human trials for structural-functional claims and NDA support data packages.
Precision manufacturing across solid oral dosage lines: softgels, beadlet capsules, effervescent powders, and microencapsulated liposomal suspensions.
Formulating targeted botanical therapies tailored to modern chronic indications and high-growth consumer wellness categories.
Bio-active berberine hydrochloride complexes, mulberry leaf (1-DNJ) extracts, and bitter melon charantin formulas engineered to modulate AMPK activation and support healthy postprandial glucose metabolism in pre-diabetic cohorts.
Synergistic matrices of standardized Bacopa monnieri, Huperzine A, and premium Panax notoginseng saponins formulated to enhance neuroplasticity, memory retention, cerebral microcirculation, and mental acuity under chronic fatigue stress.
Advanced mitochondrial vitality blends featuring high-yield Astragaloside IV, microencapsulated resveratrol, and full-spectrum Cordyceps mycelial polysaccharides designed to reduce oxidative cellular senescence and optimize systemic endocrine resistance.
Addressing structural challenges across the botanical value chain to shield global brand equity.
Solution: Yineng Pharma eliminates potency variance by conducting baseline geographical chromatography. Our proprietary seasonal profiling database enables smart multi-batch blending, maintaining strict ±2% active compound tolerances year-round.
Solution: Transitioning industrial processing toward green aqueous and clean-solvent extraction (USP/EP Grade). Every batch undergoes mandatory multi-residue pesticide screens (>500 pesticides), aflatoxin testing, and ICP-MS heavy-metal assays.
Solution: Operating strictly under entrusted confidential research agreements. All master formulas, chromatography recipes, and engineering parameters are protected within compartmentalized cleanrooms, preventing reverse engineering.
Crucial commercial, technical, and regulatory intelligence for sourcing directors and product managers.
Active compound screening and baseline HPLC validation typically take 4–6 weeks. Small-scale in vitro assays and pilot run formulations take an additional 6–8 weeks. If human safety and clinical trials are required, packages run between 4 and 10 months depending on study size and cohort requirements.
We apply our proprietary multidimensional chromatography profiling database. By testing plants harvested across multiple Chinese provinces across four seasons, our scientific team pre-determines dynamic extraction ratios to achieve uniform finished potency.
Yes. Our pilot plants and collaborative mass-production manufacturing facilities operate under comprehensive cGMP, ISO 22000, and HACCP frameworks, with full audit trail documentation and analytical certificates of analysis (COA) provided for every lot.
We supply pure active extracts (concentrated liquids, powders, pastes, volatile oils) as well as finished formats: oral liquids, softgels, hard-shell capsules, multi-layer tablets, micro-granules, and water-soluble sachets tailored to functional beverage brands.
Accelerate your formula deployment with our validated CDMO production lines and turn-key research contracts.
